BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24465425)

  • 1. Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women.
    Prior JC; Elliott TG; Norman E; Stajic V; Hitchcock CL
    PLoS One; 2014; 9(1):e84698. PubMed ID: 24465425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women.
    Hitchcock CL; Elliott TG; Norman EG; Stajic V; Teede H; Prior JC
    Menopause; 2012 Nov; 19(11):1208-14. PubMed ID: 22781788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G; Spritzer PM
    Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women.
    Mandrup CM; Egelund J; Nyberg M; Lundberg Slingsby MH; Andersen CB; Løgstrup S; Bangsbo J; Suetta C; Stallknecht B; Hellsten Y
    Am J Obstet Gynecol; 2017 Apr; 216(4):384.e1-384.e11. PubMed ID: 28024987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial.
    Samavat H; Newman AR; Wang R; Yuan JM; Wu AH; Kurzer MS
    Am J Clin Nutr; 2016 Dec; 104(6):1671-1682. PubMed ID: 27806972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes.
    Mansour A; Mohajeri-Tehrani MR; Qorbani M; Heshmat R; Larijani B; Hosseini S
    Nutrition; 2015 Jan; 31(1):119-26. PubMed ID: 25466655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.
    Teede HJ; Dalais FS; Kotsopoulos D; Liang YL; Davis S; McGrath BP
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3053-60. PubMed ID: 11443167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of isoflavones combined with soy protein on lipid profiles, C-reactive protein and cardiovascular risk among postmenopausal Chinese women.
    Liu ZM; Ho SC; Chen YM; Ho YP
    Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):712-9. PubMed ID: 21429720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial.
    Muñoz-Aguirre P; Flores M; Macias N; Quezada AD; Denova-Gutiérrez E; Salmerón J
    Clin Nutr; 2015 Oct; 34(5):799-804. PubMed ID: 25453396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranberry juice consumption lowers markers of cardiometabolic risk, including blood pressure and circulating C-reactive protein, triglyceride, and glucose concentrations in adults.
    Novotny JA; Baer DJ; Khoo C; Gebauer SK; Charron CS
    J Nutr; 2015 Jun; 145(6):1185-93. PubMed ID: 25904733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause.
    Cagnacci A; Cannoletta M; Palma F; Zanin R; Xholli A; Volpe A
    Climacteric; 2012 Apr; 15(2):157-62. PubMed ID: 22141325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
    Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
    Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study.
    Sansone R; Rodriguez-Mateos A; Heuel J; Falk D; Schuler D; Wagstaff R; Kuhnle GG; Spencer JP; Schroeter H; Merx MW; Kelm M; Heiss C;
    Br J Nutr; 2015 Oct; 114(8):1246-55. PubMed ID: 26348767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
    Hitchcock CL; Prior JC
    Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid profile comparison between pre- and post-menopausal women].
    Wang N; Qin MZ; Cui J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
    [No Abstract]   [Full Text] [Related]  

  • 20. Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.
    Archer DF; Altomare C; Jiang W; Cort S
    Menopause; 2017 Oct; 24(10):1167-1174. PubMed ID: 28509812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.